The First FDA-approved Anti-PDL1 Cancer Immunotherapy in Locally Advanced or Metastatic Urothelial Carcinoma

Amanda Bridges
October 13, 2017
e-Learning, News

Watch Here: www.tecentriq-ondemand.com

© 2021 FLASCO | Premium Website Design by The HDG